Tag: hospitals

SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the administration of the first dose of troculeucel, an expanded autologous NK cell therapy, under a single compassionate use, Investigational New Drug (“IND”) authorization cleared by the U.S. Food and Drug Administration (“FDA”), to a patient with mild-stage Alzheimer’s disease who exhibited continued cognitive decline despite ongoing treatment with lecanemab, an amyloid targeting therapy. This exploratory work is being conducted in collaboration with Anita Fletcher, M.D., a board-certified neurologist with specialized training in neuroimmunology, who also serves as Director of Neuroscience Clinical Research at AdventHealth Neuroscience Institute in Orlando, Florida.

IRVINE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Sabal Investment Holdings (“Sabal” or “SIH”) today announced the final closings of two private commercial real estate funds: Sabal Strategic Opportunities Fund II and SIH Debt Opportunities Fund III, with total capital commitments of $720 million.

 - Regina Hodits, Managing Director to join NUCLIDIUM’s Board of Directors